Scaling Science: My Precision Medicine Accessibility Mission
Sitting Down With… Luca Quagliata, Vice President and Global Head of Medical Affairs at Thermo Fisher Scientific
-
By
-
Helen Bristow
-
February 3, 2026
-
Clinical Scorecard: Scaling Science: My Precision Medicine Accessibility Mission
At a Glance
| Category | Detail |
|---|
| Condition | Precision Medicine Accessibility |
| Key Mechanisms | Collaboration between academia and industry, patient-centric approaches, and technological innovation. |
| Target Population | Global oncology community and patients requiring precision medicine. |
| Care Setting | Industry and academic partnerships. |
Key Highlights
- Leadership combines scientific expertise with business capability.
- Importance of recognizing team achievements while taking responsibility for failures.
- Continuous learning is essential for staying current in the field.
- Social responsibility is a key factor in decision-making in industry.
- Collaboration is crucial for achieving accessible precision medicine.
Guideline-Based Recommendations
Diagnosis
- Adopt a patient-centric view in all practices.
Management
- Encourage partnerships between academia, industry, and medical societies.
Monitoring & Follow-up
- Continuously assess the impact of solutions on patient accessibility.
Risks
- Misconceptions about industry motivations can hinder collaboration.
Patient & Prescribing Data
Patients globally who could benefit from precision medicine.
Current solutions are impactful but only reach a fraction of potential beneficiaries.
Clinical Best Practices
- Foster an environment that enables team decision-making.
- Maintain a broad perspective by learning outside one's field.
- Prioritize social responsibility alongside business objectives.
References
